Compositions comprising macrolide Tcell immunomodulators or immunosuppressants in combination with antibacterials

Details for Australian Patent Application No. 2004226818 (hide)

Owner Novartis AG

Inventors Paul, Carle; Sekkat, Nabila; Stutz, Anton; Hildebrandt, Johannes; Hirsch, Stefan; Ryder, Neil Stewart; Grassberger, Maximilian

Agent Davies Collison Cave

Pub. Number AU-A-2004226818

PCT Pub. Number WO2004/087143

Priority 0307862.3 04.04.03 GB

Filing date 2 April 2004

Wipo publication date 14 October 2004

International Classifications

A61K 031/436

A61P 031/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087143 Priority application(s): WO2004/087143

17 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226819-Synergistic combinations of macrolide T-cell modulator or inmunosuppressant and a retinoid

2004226815-Crystalline N-formyl hydroxylamine compounds